Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph U Correll

Showing results (81-90 of 1,042) with videos related to

Pageof 105
Sort By:
Acta Psychiatrica Scandinavica|November 14, 2024
Letter to the Editor Concerning "Glucagon-Like Peptide Agonists for Weight Management in Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis"Anders Fink-Jensen, Christoph U Correll
CNS Drugs|July 20, 2023
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in SchizophreniaJonathan M Meyer, Christoph U Correll
Neuropsychiatric Disease and Treatment|February 29, 2020
Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and TreatmentChristoph U Correll, Nina R Schooler
The Journal of Clinical Psychiatry|April 11, 2017
Duration and Relevance of Untreated Psychiatric Disorders, 1: Psychotic DisordersJose M Rubio, Christoph U Correll
JAMA Psychiatry|July 2, 2015
Antipsychotic Use in Youth Without Psychosis: A Double-edged SwordChristoph U Correll, Joseph C Blader
Evidence-Based Mental Health|July 13, 2018
Clozapine and long-acting injectable antipsychotics reduce hospitalisation and treatment failure risk in patients with schizophreniaJose M Rubio, Christoph U Correll
Journal of Child and Adolescent Psychopharmacology|November 6, 2007
One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic reviewChristoph U Correll, John M Kane
Bipolar Disorders|April 21, 2010
Primum non nocere: balancing the risks and benefits of prescribing psychotropic medications for youth with bipolar disorderMelissa P DelBello, Christoph U Correll
Therapeutic Advances in Psychopharmacology|October 23, 2018
The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analysesPeter M Haddad, Christoph U Correll
The Journal of Clinical Psychiatry|September 20, 2019
Optimizing Treatment Choices to Improve Adherence and Outcomes in SchizophreniaJohn M Kane, Christoph U Correll
Pageof 105

Showing results (81-90 of 1,042) with videos related to

Sort By:
Pageof 105
Acta Psychiatrica Scandinavica|November 14, 2024
Letter to the Editor Concerning "Glucagon-Like Peptide Agonists for Weight Management in Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis"Anders Fink-Jensen, Christoph U Correll
CNS Drugs|July 20, 2023
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in SchizophreniaJonathan M Meyer, Christoph U Correll
Neuropsychiatric Disease and Treatment|February 29, 2020
Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and TreatmentChristoph U Correll, Nina R Schooler
The Journal of Clinical Psychiatry|April 11, 2017
Duration and Relevance of Untreated Psychiatric Disorders, 1: Psychotic DisordersJose M Rubio, Christoph U Correll
JAMA Psychiatry|July 2, 2015
Antipsychotic Use in Youth Without Psychosis: A Double-edged SwordChristoph U Correll, Joseph C Blader
Evidence-Based Mental Health|July 13, 2018
Clozapine and long-acting injectable antipsychotics reduce hospitalisation and treatment failure risk in patients with schizophreniaJose M Rubio, Christoph U Correll
Journal of Child and Adolescent Psychopharmacology|November 6, 2007
One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic reviewChristoph U Correll, John M Kane
Bipolar Disorders|April 21, 2010
Primum non nocere: balancing the risks and benefits of prescribing psychotropic medications for youth with bipolar disorderMelissa P DelBello, Christoph U Correll
Therapeutic Advances in Psychopharmacology|October 23, 2018
The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analysesPeter M Haddad, Christoph U Correll
The Journal of Clinical Psychiatry|September 20, 2019
Optimizing Treatment Choices to Improve Adherence and Outcomes in SchizophreniaJohn M Kane, Christoph U Correll
Pageof 105